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72Objective: Robotic mitral valve repair is the least invasive approach to mitral valve repair, yet there are few data
comparing its outcomes with those of conventional approaches. Therefore, we compared outcomes of robotic mi-
tral valve repair with those of complete sternotomy, partial sternotomy, and right mini-anterolateral thoracotomy.
Methods: From January 2006 to January 2009, 759 patients with degenerative mitral valve disease and posterior
leaflet prolapse underwent primary isolated mitral valve surgery by complete sternotomy (n¼ 114), partial ster-
notomy (n ¼ 270), right mini-anterolateral thoracotomy (n ¼ 114), or a robotic approach (n ¼ 261). Outcomes
were compared on an intent-to-treat basis using propensity-score matching.
Results:Mitral valve repair was achieved in all patients except 1 patient in the complete sternotomy group. In
matched groups, median cardiopulmonary bypass time was 42 minutes longer for robotic than complete sternot-
omy, 39 minutes longer than partial sternotomy, and 11 minutes longer than right mini-anterolateral thoracot-
omy (P< .0001); median myocardial ischemic time was 26 minutes longer than complete sternotomy and
partial sternotomy, and 16 minutes longer than right mini-anterolateral thoracotomy (P<.0001). Quality of mi-
tral valve repair was similar among matched groups (P ¼ .6, .2, and .1, respectively). There were no in-hospital
deaths. Neurologic, pulmonary, and renal complications were similar among groups (P>.1). The robotic group
had the lowest occurrences of atrial fibrillation and pleural effusion, contributing to the shortest hospital stay
(median 4.2 days), 1.0, 1.6, and 0.9 days shorter than for complete sternotomy, partial sternotomy, and right
mini-anterolateral thoracotomy (all P<.001), respectively.
Conclusions: Robotic repair of posterior mitral valve leaflet prolapse is as safe and effective as conventional
approaches. Technical complexity and longer operative times for robotic repair are compensated for by lesser
invasiveness and shorter hospital stay. (J Thorac Cardiovasc Surg 2011;141:72-80)Supplemental material is available online.e Heart and Vascular Institute, Department of Thoracic and Cardiovascular
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The Journal of Thoracic and Cardiovascular SurgeLess invasive approaches for treating myxomatous mitral
valve (MV) disease were introduced to reduce trauma
while preserving the safety and quality achieved by sur-
gery through complete sternotomy.1-5 Partial sternotomy
and limited right mini-anterolateral thoracotomy reduced
incision size while still allowing surgery under direct visu-
alization using conventional instruments.1,4,6 Robotic MV
repair represents the latest development in less invasive
surgery.7,8 Despite obvious potential benefits of reduced
trauma and improved cosmesis, acceptance of robotic
MV repair has been limited because of concern about its
complexity, prolonged operative time, quality of repair,
and cost.9,10
Comparisons of its safety and effectiveness with other
less invasive approaches have been based on heterogeneous
patient cohorts, with variable extent of myxomatous
disease, and often historic rather than concurrent con-
trols.7,11,12 The purpose of this study was to provide
a contemporary comparison of the safety and efficacy of
robotic MV repair with those of complete sternotomy,
partial sternotomy, and mini-anterolateral thoracotomy in
concurrently treated patients with myxomatous MV disease
limited to posterior leaflet repair.ry c January 2011
Abbreviations and Acronyms
ANT ¼ mini-anterolateral thoracotomy
CST ¼ complete sternotomy
MR ¼ mitral regurgitation
MV ¼ mitral valve
PST ¼ partial sternotomy
ROB ¼ robotic
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Patients
From January 1, 2006, to January 1, 2009, 759 patients with degenera-
tive MV disease limited to the posterior leaflet underwent primary isolated
MV repair at Cleveland Clinic via complete sternotomy (CST; n ¼ 114),
partial sternotomy (PST; n ¼ 270), mini-anterolateral thoracotomy
(ANT; n ¼ 114), or a robotic (ROB; n ¼ 261) approach. Patients who un-
derwent concomitant procedures were not included, with the exception of
patent foramen ovale or atrial septal defect closure and left-sided ablative
procedures for atrial fibrillation. Patient characteristics, including descrip-
tion of the extent and morphology of MV disease, are shown in Table 1.
Although 17 patients had a moderate (2þ) degree of mitral regurgitation
(MR) on preoperative transthoracic echocardiography, all had severe MR
on transesophageal or stress echocardiography.
Surgical Technique
Conventional general anesthesia was used in all patients, with dual-
lumen endotracheal intubation and isolated left lung ventilation for the
ROB or ANT approach. All operations were performed on cardiopulmo-
nary bypass at normothermia or mild hypothermia, with the use of ante-
grade and retrograde cold blood cardioplegia.
For CST, cardiopulmonary bypass was instituted by cannulating the dis-
tal ascending aorta and superior and inferior venae cavae, and the MV was
exposed through a left atriotomy. For PST, the operation was performed
through division of the upper sternum, as previously described.13 ANT
was performed through the fourth intercostal space with the use of
femoro-femoral cardiopulmonary bypass.4 ROB MV repair was accom-
plished with the use of robotic surgical instrumentation via a mini-
thoracotomy or endoscopic ports.
For ANTand ROB, cardiopulmonary bypass was established by cannu-
lating the femoral artery and vein, with optional cannulation of the superior
vena cava through the right internal jugular vein. After pericardiotomy, for
ANT, the ascending aorta was generally occluded with a transthoracic
clamp or occasionally with an endoballoon; for ROB, the ascending aorta
was occluded with an endoballoon or transthoracic clamp.
For ROB, the left arm of the robot was inserted through the third intercos-
tal space in the anterior-axillary line and the right arm was inserted through
the fifth intercostal space in the mid-axillary line. A mini-thoracotomy or
working port was placed in the fourth intercostal space in the mid-axillary
line, and a dynamic left atrial retractor was placed in the mid-clavicular line.
MVrepairwas accomplishedusing triangular or quadrangular resection of
the prolapsed segment (Table E1). Artificial polytetrafluoroethylene chordae
were used for leaflet repair in patients with extensive posterior leaflet pro-
lapse. Edge-to-edge leaflet repair was used primarily for prolapse of lateral
or medial posterior leaflet scallops. A partial flexible anuloplasty band (Cos-
grove-EdwardsAnnuloplastySystem,EdwardsLifesciences, Inc, Irvine,CA)
was used in all but 1 patient, inwhom theMVwas replaced after failed repair.
Data
Preoperative and operative variables were retrieved from the Cardiovas-
cular Information Registry, an ongoing, prospective, concurrent registry ofThe Journal of Thoracic and Call cardiac operations; these were augmented by data from echocardiogra-
phy, cardiac anesthesia, laboratory medicine, and operating room data-
bases. Pain scores were retrieved manually and from the Electronic
Health Record. The institutional review board approved all databases for
research, with patient consent waived.
Outcomes
Effectiveness of surgical approaches included evaluation of operative
variables (intraoperative, cardiopulmonary bypass, and myocardial ische-
mia times) and efficacy of MV repair. Assessment of efficacy was based
on routine predischarge transthoracic echocardiography. Severity of MR
was graded as 0 ¼ none, 1þ¼ mild, 2þ¼ moderate, 3þ¼ moderately
severe, and 4þ¼ severe. All results were interpreted on an intent-to-treat
basis, with conversions in operative approach recorded and reasons ana-
lyzed separately. In addition, we analyzed differences in hematocrit and
mediastinal drainage, postoperative intubation time, length of postopera-
tive hospital stay, and pain scores.
Pain intensity was recorded as part of clinical care by nursing staff from
patients’ arrival in the intensive care unit to hospital discharge, using the
Wong–Baker visual-analog scale.14 A total of 40,755 pain scores were
available for 756 patients (99.6%; Figure E1). Pain management during
this time frame was uniform and included narcotic patient-controlled anal-
gesia on the first and second postoperative days and oral analgesics and
nonsteroidal anti-inflammatory agents thereafter. Because of the nature
of patient-controlled analgesia, the temporal pattern of analgesia use could
not be retrieved via the Electronic Health Record.
Safety of operative approach was assessed by comparing mortality and
morbidity, defined in accordance with the Society of Thoracic Surgeons
National Database (see http://www.ctsnet.org/file/rptDataSpecifications
252_1_ForVendorsPGS.pdf).
Data Analysis
Propensity matching. A number of differences in patient character-
istics precluded unadjusted comparisons of outcomes. To reduce selection
bias, we used propensity matching to approximate a randomized trial.15 Be-
cause our focus was on patients who received ROBMV repair, we created 3
separate propensity models for ROB versus CST, ROB versus PST, and
ROB versus ANT. To construct the propensity score, we used preoperative
and procedure variables (Appendix 1) and multivariable logistic regression
to initially identify factors associated with ROB surgery versus CST, PST,
or ANT. Having established a parsimonious model, we added other vari-
ables representing groups of patient factors that might be related to unre-
corded selection factors (semi-saturated model).16 A propensity score
was calculated for each patient by solving the resulting propensity models
for the probability of receiving ROB MV repair.17 By using only the pro-
pensity score, ROB cases were matched to non-ROB cases by greedy
matching.18 ROB cases whose propensity scores deviated more than 0.1
from those of non-ROB cases were considered unmatched (Figure E2).
Comparisons. Categoric variables were compared using the chi-
square or Fisher’s exact test when frequency was less than 5. For continu-
ous variables, pairwise comparisons were made using the t test orWilcoxon
rank-sum nonparametric test for skewed distributions and the Kruskall–
Wallis test for comparisons of more than 2 groups. All analyses were per-
formed using SAS statistical software (SAS v9.1; SAS, Inc, Cary, NC).
To compare temporal pattern of postoperative pain across time, pain
scores were combined into 5 categories because of low frequency of higher
pain scores: 0 (pain score 0), 1 (pain scores 1–3), 2 (pain scores 4–6), 3
(pain scores 7 and 8), and 4 (pain scores 9 and 10). These pain score cate-
gories were analyzed longitudinally for change. A nonlinear, cumulative
logit mixed model was used to resolve a number of time phases in the
cumulative odds domain to form a temporal decomposition model and to
estimate the shaping parameters for each phase.19 Each phase was indepen-
dently modulated by a time function with common random intercept to ac-
commodate the repeated nature of the data. Longitudinal cumulativeardiovascular Surgery c Volume 141, Number 1 73
TABLE 1. Patient characteristics of all patients according to surgical approach
Complete sternotomy
(total n ¼ 114)
Partial sternotomy
(total n ¼ 270)
Mini-anterolateral thoracotomy
(total n ¼ 114)
Robotic approach
(total n ¼ 261)
Characteristic n*
No. (%) or
mean ± SD n*
No. (%) or
mean ± SD n*
No. (%) or
mean ± SD n*
No. (%) or
mean ± SD P
Demography
Female 114 29 (25) 270 74 (27) 114 29 (25) 261 57 (22) .5
Age (y) 114 61  11 270 57  12 114 55  11 261 56  11 .0003
BMI (kg/m2) 114 27  5.4 270 26  3.6 114 27  5.0 261 26  4.3 .3
Symptoms
NYHA functional class 114 270 114 261 .009
I 37 (32) 120 (44) 57 (50) 131 (50)
II 54 (47) 128 (47) 47 (41) 97 (37)
III 22 (19) 20 (7.4) 10 (8.8) 31 (12)
IV 1 (0.88) 2 (0.74) 0 (0) 2 (0.77)
LVEF (%) 111 59  5.7 269 60  4.6 114 59  4.4 258 60  4.4 .1
Heart failure 114 22 (19) 270 20 (7.4) 114 4 (3.5) 261 19 (7.3) <.0001
Cardiac morbidity
MR grade 114 270 114 261 .9
2þy 4 (3.5) 6 (2.2) 3 (2.6) 4 (1.5)
3þ 17 (15) 45 (17) 22 (19) 46 (18)
4þ 93 (82) 219 (81) 89 (78) 211 (81)
Atrial fibrillation/flutter 114 8 (7.0) 270 4 (1.5) 112 2 (1.8) 259 13 (5.0) .02
Previous MI 114 8 (7.0) 270 6 (2.2) 114 5 (4.4) 261 4 (1.5) .02
Noncardiac comorbidity
Carotid disease 114 12 (11) 270 26 (9.6) 114 4 (3.5) 261 29 (11) .1
Stroke 114 2 (1.8) 270 6 (2.2) 114 1 (0.88) 261 3 (1.1) .7
PAD 114 3 (11) 270 26 (9.6) 114 4 (3.5) 261 29 (11) .1
Hypertension 113 52 (46) 267 109 (41) 110 51 (46) 255 102 (40) .5
Diabetes
Insulin treated 113 0 (0) 265 1 (0.38) 108 0 (0) 254 0 (0) .6
Non-insulin treated 113 6 (5.3) 265 8 (3.0) 108 3 (2.8) 254 5 (2.0) .4
Creatinine (mg/dL) 114 0.98  0.19 270 1.0  0.76 114 0.99  0.18 261 0.99  0.2 .1
Smoking 113 38 (34) 265 74 (28) 108 32 (30) 255 88 (35) .4
COPD 114 10 (8.8) 270 9 (3.3) 114 4 (3.5) 261 10 (3.8) .09
BMI, Body mass index; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction;MI,myocardial infarction;MR,mitral regurgitation; NYHA,New
York Heart Association; PAD, peripheral arterial disease; SD, standard deviation. *Patients with data available. ySee text for details.
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was used to implement the temporal decomposition model.20,21
Prevalence of each pain score category over time was estimated by
averaging patient-specific profiles.
Presentation
Continuous variables are summarized by mean  standard deviation or
by median and 15th and 85th percentiles, consistent with  1 standard de-
viation. Categoric data are summarized by frequencies and percentages.
RESULTS
Effectiveness
MV repair was accomplished in all patients except 1
patient in the CST group (Table E1).
Among matched patients, the ROB group had the longest
operative times (median, 387 minutes), 109, 110, and 60
minutes longer than the CST, PST, and ANT groups (all
P<.0001), respectively (Figure 1). The ROB group also
had the longest cardiopulmonary bypass times (median74 The Journal of Thoracic and Cardiovascular Surge116 minutes), 42, 40, and 10 minutes longer than for the
CST, PST, and ANT groups (all P< .007), respectively
(Figure E3). Median myocardial ischemia time for the
ROB group was 85 minutes, 28, 26, and 19 minutes longer
than for the CST, PST, and ANT groups (all P<.0001), re-
spectively. These times have all steadily decreased across
time (Figure E4).
Quality of MV repair was similar among matched
groups, with more than 95% of patients having no or
mild residual MR on postoperative (predischarge) transtho-
racic echocardiogram (P ¼ .6, .2, and .1, respectively;
Table 2).
Conversion for the ROB approach was 9.1% (24/261),
compared with 2.6% (7/270) for PST and 2.6% (3/114) for
ANT. Thirteen of the 24 conversions occurred before robot
docking because anatomic factors precluded safe peripheral
cannulation (small or arteriosclerotic femoral vessels;
Table 3). Four of the conversions occurred after docking butry c January 2011
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FIGURE 1. Intraoperative times (minutes) according to approach,
propensity-matched patients. A, Total operative time. B, Cardiopulmonary
bypass time. C,Myocardial ischemic time. ANT, Mini-anterolateral thora-
cotomy; CST, complete sternotomy; PST, partial sternotomy; ROB, robotic
surgery.
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endoballoon-administered cardioplegia. Seven of the conver-
sions occurred after atrial incision because of bleeding, in-
ability to arrest the heart, or repair failure.The Journal of Thoracic and CSafety
There were no operative deaths. Complications defined
by the Society of Thoracic Surgeons were similar among
matched groups (Table 4). Reoperation for postoperative
bleeding and blood product use were similar among groups.
Despite differences in size and location of incisions, pain
scores after ROB surgery were similar to those in the CST
and PST groups, with 70% of patients reporting no or little
pain by the fourth postoperative day (Figure E5), but lower
than after ANT procedures. The lowest prevalence of new
postoperative atrial fibrillation/flutter (24%) was observed
in the ROB group, 14% (P ¼ .5), 13% (P ¼ .002), and
7% (P ¼ .3) lower than the CST, PST, and ANT groups,
respectively.
Amongmatched patients, the ROB group had the shortest
postoperative hospital stay (median, 4.2 days), 1.0, 1.6,
and 0.9 days less than the CST, PST, and ANT groups (all
P<.001).DISCUSSION
Invasiveness of MV surgery is to a large degree related to
incisional trauma. Size of all surgical incisions is determined
by the need for (1) direct visualization of the operative field
and (2) enough space for the surgeon’s hands and instruments
to perform the operation. Extent of reduction in incision size
and associated surgical trauma to patients with partial ster-
notomy and right thoracotomy were limited by the need
for direct visualization and use of standard surgical instru-
mentation. Introduction of video-assisted mitral surgery
via mini-thoracotomy has proven to be safe and effective,
but has gained limited following because of difficulties in
manipulating long-shafted instruments in a 2-dimensional
operative field and lack of surgical assistance.1,4 A robotic
surgical system, with its 3-dimensional high-definition im-
aging and sophisticated articulated microinstrumentation,
favorably influences both determinants of surgical invasive-
ness and allows MV repair to be conducted with the least
degree of surgical trauma.7,8,12 Despite initial favorable
reports, concerns about complexity and cost of the
procedure, as well as its quality and safety, have limited its
acceptance.9,10 This study provides a contemporary
concurrent evaluation of safety and efficacy of robotic MV
repair versus those obtained with complete sternotomy and
alternative less invasive approaches.Key Findings
Our study demonstrates that robotically assisted MV re-
pair is as safe and effective as repair accomplished though
complete sternotomy, partial sternotomy, and mini-right
thoracotomy. Complexity of the robotic procedure is re-
flected in longer operative times; however, less invasiveness
resulted in less morbidity and shorter hospital stay.ardiovascular Surgery c Volume 141, Number 1 75
TABLE 2. Efficacy of mitral valve repair, assessed by grade of postoperative mitral regurgitation measured by predischarge transthoracic
echocardiography*
Complete sternotomy vs
robotic approach
(106 matched pairs)y
Partial sternotomy vs
robotic approach
(223 matched pairs)y
Mini-anterolateral thoracotomy vs
robotic approach
(113 matched pairs)y
Complete
sternotomy
Robotic
approach
Partial
sternotomy
Robotic
approach
Mini-anterolateral
thoracotomy
Robotic
approach
Mitral regurgitation grade No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
0/1þ 102 (99) 101 (98) 218 (99) 213 (97) 111 (99) 107 (96)
2þ 1 (0.97) 2 (1.9) 2 (0.91) 6 (2.7) 1 (0.89) 5 (4.5)
P .6 .2 .1
*Each of the 3 comparisons in the table reflects separately propensity-matched patient groups. yEntries not adding to total matched pairs represent missing data.
TABLE 3. Conversions in all patients according to surgical approach
Reason for conversion
Time of conversion No. Bleeding
Failed repair using
initial approach Patient anatomy Inability to arrest Other
Partial sternotomy
Before atrial incision 6 3 — 1 — 2
After atrial incision 1 1 — — — —
Mini-anterolateral thoracotomy
Before atrial incision 2 — — 2 — —
After atrial incision 1 — — — — 1
Robotic approach
Before docking robot 13 — — 13 — —
After docking robot but before atrial incision 4 — — 1 3 —
After atrial incision 7 3 2 — 2 —
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Longer operative times for robotic MV repair are the re-
sult of greater complexity of anesthesiologic preparation of
the patient and greater operative complexity. Placement of
a double-lumen endotracheal tube and echo-guided percu-
taneous insertion of the retrograde cardioplegia catheter
are time-consuming and responsible for one third of the
time difference between complete sternotomy (the shortest)
and robotic approaches. Although cardiopulmonary bypass
and myocardial ischemic times were statistically signifi-
cantly longer for patients undergoing robotic surgery than
in other groups, these differences were smaller and clini-
cally less relevant than in previously published series on ro-
botic MV repair.7,12,22 Shorter myocardial ischemic time in
our series is a result of simplified leaflet repair techniques
and a novel anuloplasty technique that uses running
mattress suture for faster insertion of the anuloplasty
band.23,24 Although these times are still somewhat longer
than for conventional procedures, they are comparable to
those reported for conventional less invasive MV
operations. Furthermore, prolonged operative times for
robotic repair reflect a learning curve inevitably present in
adopting new surgical techniques.25
Conversion to alternative approaches was highest in the
robotic group; most conversions were due to size and mor-76 The Journal of Thoracic and Cardiovascular Surgephology of femoral vessels that precluded safe peripheral
cannulation. Those patients were mostly converted to
PST, another less invasive approach that allows safe estab-
lishment of cardiopulmonary bypass via central cannula-
tion. These findings have affected our preoperative
workup, and we now routinely perform computed tomogra-
phy of the aorta and duplex ultrasound of the femoral ves-
sels to assess their diameter and degree of arteriosclerosis.
Several conversions were due to failure to adequately arrest
the heart with the aortic endoballoon, with secondary diffi-
culties in adequately delivering antegrade cardioplegia.
Asymmetry in balloon design, which opposes the central lu-
men of the cardioplegia delivery catheter against the aortic
wall, resulted in inadequate rate of antegrade cardioplegia
delivery. Recent changes in catheter design have resolved
this problem. Conversions from the robotic approach after
the robotic instruments were inserted into the chest were
rare and did not result in compromised valve repair or ad-
verse outcomes.
Although we use the robotic approach for all patients
with MV prolapse regardless of complexity and extent of
disease, we limited this study to patients undergoing iso-
lated posterior leaflet repair to ensure comparable complex-
ity of myxomatous MV disease. MV repair quality in this
group mirrors our results obtained with conventionalry c January 2011
TABLE 4. Safety of mitral valve repair as reflected in postoperative morbidity and blood product requirements*
Complete sternotomy vs
robotic approach
(106 matched pairs)
Partial sternotomy vs
robotic approach
(223 matched pairs)
Mini-anterolateral thoracotomy vs
robotic approach
(113 matched pairs)
Complete
sternotomy
Robotic
approach
Partial
sternotomy
Robotic
approach
Mini-anterolateral
thoracotomy
Robotic
approach
Morbidity No. (%) No. (%) P No. (%) No. (%) P No. (%) No. (%) P
Reoperation for bleeding 4 (3.8) 4 (3.8) 1.0 11 (4.9) 19 (4.5) .8 2 (1.8) 7 (6.2) .09
Blood product use
RBC (units) .1 .2 .5
0 90 (85) 98 (92) 202 (91) 199 (89) 107 (95) 101 (89)
1 9 (8.5) 3 (2.8) 11 (4.9) 10 (4.5) 3 (2.7) 5 (4.4)
2 6 (5.7) 2 (1.9) 9 (4.0) 7 (3.1) 1 (0.88) 2 (1.8)
3 1 (0.94) 3 (2.8) 1 (0.45) 7 (3.1) 2 (1.8) 5 (4.4)
Platelets 5 (4.7) 5 (4.7) > .9 11 (4.9) 15 (6.7) .4 0 (0) 10 (8.8) .001
Cryoprecipitate 0 (0) 1 (0.94) .3 0 (0) 3 (1.3) .08 0 (0) 1 (0.88) .3
Stroke 1 (0.94) 2 (1.9) .6 7 (3.1) 6 (2.7) .8 0 (0) 2 (1.8) .2
New-onset atrial fibrillation/flutter 32 (30) 28 (26) .5 78 (35) 49 (22) .002 29 (26) 22 (19) .3
Hypoperfusion 12 (11) 9 (8.5) .5 26 (12) 25 (11) .9 11 (9.7) 12 (11) .8
Ventilated>24 h 3 (2.8) 2 (1.9) .6 5 (2.2) 11 (4.9) .1 1 (0.88) 4 (3.5) .2
Pleural effusion 9 (8.5) 0 (0) .002 19 (8.5) 4 (1.8) .001 2 (1.8) 2 (1.8) 1.0
All STS reported complications 10 (9.4) 9 (8.5) .8 22 (9.9) 24 (11) .8 3 (2.7) 14 (12) .006
RBC, Red blood cells; STS, Society of Thoracic Surgeons. *As in Table 2, each of the 3 comparisons reflects separately propensity-matched patient groups.
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ous robotic studies.26 We believe that excellent 3-dimen-
sional visualization of the operative field and superior
handling of robotic instruments allow excellent quality of
MV repair.
Safety
Safety of robotic MV repair has been well documented in
prior studies; however, a recent Society of Thoracic Sur-
geons’ survey revealed increased risk of neurologic compli-
cations in patients undergoing less invasive MV surgery.27
The choice of surgical approach in our study did not affect
occurrence of neurologic, renal, or respiratory complica-
tions, confirming the safety of robotically assisted surgery.
We believe that neurologic complications after less invasive
MV surgery are in large part due to retrograde embolism of
arteriosclerotic material from the descending aorta and iliac
and femoral vessels. Preoperative computed tomography of
the descending aorta and duplex ultrasound studies of the
femoral vessels allow detection of patients with important
arteriosclerosis for whom an alternative operative approach
should be chosen.
Fewer occurrences of atrial fibrillation in the robotic
group likely reflect a lesser degree of atrial trauma. This
is because MV repair is approached robotically through
an incision on the right lateral chest wall, permitting expo-
sure of the MV in its normal anatomic position. This
requires a small left atriotomy and minimal manipulation
of surrounding atrial tissue that may result in low occur-
rence of postoperative atrial fibrillation. In conventional op-
erations via median or partial sternotomy, exposure of theThe Journal of Thoracic and CMV is accomplished via left atriotomy or transseptally.
Large atrial incisions are needed in both cases because the
MVmust be brought into the surgeon’s view from its natural
position facing the right side of the chest. We postulate that
resulting substantial trauma of atrial tissue increases the po-
tential for postoperative atrial fibrillation. This is most ob-
vious in the partial sternotomy group, in which extensive
incision through the atria and interatrial septum is needed
for MV exposure. In contrast, MV repair through median
sternotomy was most commonly performed via left atriot-
omy, thus limiting dissection of atrial tissue and resulting
in postoperative atrial fibrillation occurrence comparable
to that of robotic repairs.
Although some studies have reported a decrease in pain
after minimally invasive surgery, we could not demonstrate
differences in postoperative pain scores in our patients ex-
cept for those having a mini-anterolateral incision.26,28
This may be explained by the relatively small patient
populations studied and excellent pain management, with
near complete pain relief by the fourth postoperative day.
Shorter hospital stay after robotic MV repair, despite lon-
ger operative times and a similar degree of postoperative
discomfort, is most likely due to a combined result of lower
occurrence of atrial fibrillation and common complications
such as pleural effusions and hemothorax.
Strengths and Limitations
This is a single-institution clinical study with analysis of
outcomes limited to hospital course. However, the Cleve-
land Clinic has one of the largest MV repair volumes,
with all surgeons highly experienced in repair techniques.ardiovascular Surgery c Volume 141, Number 1 77
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erence and not standardized. A strength of this heterogene-
ity in approach, however, is that we were able to evaluate
approaches concurrently. We tried to compensate for bias
in patient selection by propensity matching patients with
similar comorbidities and similar extent of MV disease.
Long-term follow-up is needed to fully evaluate compara-
tive effectiveness of robotic MV repair.
CONCLUSIONS
Robotically assisted MV repair represents the least inva-
sive form ofMV surgery without a compromise in quality of
valve repair or patient safety, and should therefore be con-
sidered for all patients with severemyxomatousMV disease
and posterior leaflet prolapse. Ongoing refinements of ro-
botic instrumentation and development of ancillary technol-
ogies will facilitate wider adoption of this technique in
contemporary surgical practice.
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Dr Vivek Rao (Toronto, Ontario, Canada). The authors are to
be congratulated. There is clearly a patient- and provider-driven
desire to move toward minimally invasive surgery. Many studies,
including several from the Cleveland Clinic, have shown that
this can be done. I am pleased that the authors have now focused
their attention on whether or not this should be done.
I want to point out a few caveats. This is a study performed by
a large-volume center by several experienced valve surgeons. Their
outstanding clinical results include zero mortalities in 750 mitral
repairs and only 1 failure to repair a valve. Before we start taking
this procedure home to our own institutions, we have to keep that
in mind that in these excellent hands their results are spectacular.
Despite those spectacular clinical outcomes, there were certain
drawbacks to MV surgery done with robotic assistance. Clearly,
as you have shown, operative times are longer, cardiopulmonary
bypass times are longer, and ischemic times are longer, and this
in a cohort of patients who had relatively easy MVs to repair, iso-
lated posterior leaflet prolapse. Are these differences magnified
when we start to challenge the more complex MV?
Third, you indicated there was no significant difference in
bleeding or transfusion requirements among the groups; however,
it was interesting to note that massive transfusion requirements,
defined as more than 3 units of packed red blood cells, was actually
higher in the robotic group. Does that mean that when things go
bad with robotic surgery, things go really bad?
I also point out that the length of stay reductions that we ob-
served were less than overwhelming, an average of 1 median
day less, and what you did not present but was present in your ar-
ticle was that there was actually no difference in pain scores be-
tween robotic surgery and even complete sternotomy, and that
was somewhat surprising to me.ry c January 2011
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DThat leads me to question a few things about your study from
a philosophical nature. What is the real goal of robotic minimally
invasive surgery? Is it to improve the quality and the physiologic
recovery of patients or is it for cosmesis? If the former, a simple
walk through our exhibit hall will show many companies that
show sternal fixation devices that allow patients to go home 2 to
3 days after surgery, which would be a dramatic improvement
compared with even the excellent results that you show here.
Last, I caution people in compromising the integrity of their
overall medical management simply to achieve minimally invasive
surgery. If we can achieve similar results with good physiologic re-
covery with a full sternotomy and perform all the technical proce-
dures that are needed to be done on a patient, I think that should be
paramount. There is a tendency in the real world to compromise
our patients by doing, for example, a percutaneous stent to the
left anterior descending artery to facilitate port-access MV surgery
and perhaps not do what is in the best interest of our patients.
Once again, these are philosophical questions at most, and I
thank the Association for the privilege of discussing this article.
Dr Mihaljevic. Your first question is whether this is a cosmesis
versus quality. Our entire study was designed to show that there
was no compromise in quality. We report essentially 100% mitral
valve repair rate with zero mortality. It is difficult to argue that
there is a compromise in quality with such results.
It is also difficult to show, as you said, a spectacular reduction in
hospital length of stay for operations that normally do not require
a long hospital stay anyhow. So it is not to be expected that a patient
after general anesthetic and cardiopulmonary bypass is going to
leave the hospital on postoperative day 2 no matter what we do,
and you are right about that. I think one of the real advantages
of this approach, which is not analyzed in this study, is the fact
that these patients do return to their regular activities of daily
life substantially faster than those who have a complete sternot-
omy, and that has been our experience.
Now, as I said, when it comes to the bleeding, yes, we have had,
obviously, conversions. You have to understand that these are the
patients whom we analyzed with an intent to treat, so we have
not tried to hide the complications that occur with occasional con-
versions, but those were rare and they have not compromised the
overall outcome of our patients in this study, as I hope that this
is well documented with our results and analysis.
DrHarold Roberts (Lauderdale Lakes, Fla). I have a couple of
questions, and one of them is, indeed, your bypass and ischemic
times were longer in this subset of patients. Have you in fact broken
downwith time to see if there has been improvement in this overall,
because I know in my own experience that the times in the first few
cases have dramatically improved over the last several months.
DrMihaljevic. That is true. In regard to ischemic and cardiopul-
monary bypass time, I would just like to remind you that the abso-
lute crossclamp time, the length of the crossclamp time, is 80
minutes for all-comers, including those first patients who clearly
had somewhat longer bypass times, but none of our patients required
excessively long crossclamp times in excess of 120 minutes. If you
compare this with even most recently published series on complete
sternotomy or mini-anterolateral thoracotomy, you will find that
these absolute times are shorter than any of the previously published
series. And, of course, as we became more facile, the crossclamp
times have become shorter and shorter, so that our crossclampThe Journal of Thoracic and Ctime now averages approximately 70minutes regardless of the com-
plexity of MV repair that we need to do with the robot.
Dr Roberts. Two more questions. In light of your initial success
with a P2 prolapse, have you tried to do more complex repairs with
this approach? Finally, I noticed you had a significant conversion
rate when you found heavily diseased or inadequate vessels. I think
that a useful adjunct, and I wonder if you had incorporated this, is to
now use preoperative computed tomography angiography. You can
know exactly what size cannulas are going to work and which pa-
tients should not undergo operation because of atheromatous debris.
Dr Mihaljevic. To answer your first question, we use the ro-
botic approach for any patients with myxomatous MV disease re-
gardless of theMV disease complexity. And, yes, we have changed
our preoperative approach. Now we use a computer-assisted to-
mography scan and a femoral ultrasound to identify those patients
who have aortoiliac or femoral artery disease.
DrRalph Damiano (St. Louis, Mo). I disclose I am a consultant
for AtriCure and Medtronic. I was wondering why you confined
the study just to posterior leaflet disease. In your conclusion you
say that robotics is safe and effective for all myxomatous disease.
Maybe you could clarify this comment with your present experi-
ence. Are there patients with complex disease for whom you do
not recommend a robotic approach? Are your results generalizable
to more complex mitral repair?
Dr Mihaljevic.We have purposely defined this cohort as a co-
hort of patients when we did the repair to the posterior leaflet. It
doesn’t mean that these patients did not have a bileaflet prolapse
based on the preoperative echo, and quite a few patients, as you
know, who have a bileaflet prolapse can be repaired by taking
care of the posterior leaflet prolapse and putting in an annuloplasty
ring. So we wanted to have this cohort stratified in such a way that
it reflects accurately the procedural complexity. I think your com-
ment is relevant.
I have to say today in our current practice, as I mentioned be-
fore, robotic MV repair is offered to all patients with myxomatous
MV disease regardless of the complexity of their disease.
Dr Damiano. I noticed you did not present any cost data. Did
you look at whether there were increased hospital costs by using
a robotic system?
DrMihaljevic. The purpose of this study is to assess the proce-
dural safety and efficacy. We are actively looking into cost, and not
only cost of hospitalization but the costs and benefits of this pro-
cedure that extend beyond the hospital stay, and we hope to have
data to present soon, but just to share with you that there is a minor
difference in hospital cost.
Dr Damiano. In the patients who underwent mini-anterolateral
thoracotomies, what was your surgical technique? What was the
size of the thoracotomy? Did you try to avoid rib spreading? Did
you use specialized instrumentation? You can make a very small
incision with current techniques.
DrMihaljevic.Yes, it is a very small incision, anterolateral tho-
racotomy, sometimes without rib spreading, sometimes with rib
spreading, long-shafted instruments, most of the times direct trans-
thoracic crossclamping, occasional endo balloon.
Dr Antonio Laudito (Wichita, Kan). I was a bit surprised, and I
would like to know what you think. One of the minimal approaches
to attack the MV that Dr Larry Cohn proposes is the lower inferior
sternotomy, and, despite that, you presented the upper part. Theardiovascular Surgery c Volume 141, Number 1 79
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you. You use the same perfusion, cannulation, cardioplegia strategy
as inmedian sternotomy.Youdon’t needdouble lumen. It is a simple
approach if you are on top of theMV.And Iwaswondering,what do
you think about this approach that I didn’t see mentioned?
Dr Mihaljevic. Having been trained at the Brigham, I am per-
fectly familiar with it. A partial sternotomy does the same thing.
With the partial upper sternotomy, it is direct central cannulation,
usual instruments. It is just a preferred approach at the Cleveland
Clinic. But I am familiar with Dr Cohn’s approach and have done it
many times.
Dr Robert Higgins (Chicago, Ill). Impressive data. Do you
have any information about the completeness of follow-up, your
mortality after hospitalization, and the efficacy of the repair be-
yond hospitalization?
DrMihaljevic.We are going to have a complete 2-year follow-
up soon. As you may have noticed, this cohort included patients up
to January of 2009, so wewill have 2-year completeness data soon.
We have not had a single mortality beyond the usual 30 days, an in-
hospital mortality, that we know for a fact.
Dr Higgins. And the completeness of your follow-up?
Dr Mihaljevic. As I said, we have not completed a 2-year
follow-up because this is a recent study.
Dr David Adams (New York, NY). I am an inventor of annulo-
plasty rings with Edwards Lifesciences.
Tommy, I rise to congratulate you. This is a master series by
master surgeons. Your robotic series over a 2-year period is really
unbelievable, an amazing amount of work.APPENDIX 1. Variables used in the analyses
Demographics Age,*,z,{ sex,y,x,{ height (cm), weigh
Cardiac morbidity Atrial fibrillation,z,{ ventricular arrhy
Noncardiac comorbidity Chronic obstructive pulmonary diseas
smokingy,z
Laboratory medicine Blood urea nitrogen (mg/dL),x,{ chol
lipoprotein (mg/dL), creatinine (mg
Preoperative symptoms New York Heart Association function
Experience Interval (years) from January 2006 to
Preoperative echocardiogram values MV regurgitation,y,x aortic valve regu
systolic dysfunction (1 ¼ none, 2 ¼
end-diastolic volume (mL),y LV inn
shortening, LVejection fraction (%)
LV relative wall thickness (mm), LV
systolic pressure (mm Hg)k
MV pathology MV calcification,z posterior chordal r
ANT, Mini-anterolateral thoracotomy; CST, complete sternotomy; LV, left ventricular;MV,
ROB parsimonious model. yVariables in CST versus ROB saturated model. zVariables in P
kVariables in ANT versus ROB parsimonious model. {Variables in ANT versus ROB satu
80 The Journal of Thoracic and Cardiovascular SurgeI have 2 short questions. One, you didn’t show us a summary
of techniques. Have you altered your techniques of valve repair
based on robotics, for instance, less resection, less sliding plasty,
more polytetrafluoroethylene? Second, it looks like from your
data that at least in well-selected patients with degenerative
and predominantly posterior leaflet prolapse you could offer
many different incision options reproducibly. So institutionally
how are you approaching that? Obviously different surgeons
have different skill sets and biases. Are you offering approaches
to all patients or is that still surgeon based? I think it is an inter-
esting thing for you to comment on. Congratulations on your fine
series.
Dr Mihaljevic. To answer your question first, yes, just like any
other surgical technique, our repair techniques have evolved over
time. Generally speaking, for patients who have a limited MV pro-
lapse, we would use resectional techniques; for those who have
a more diffuse MV prolapse, whether it is the bileaflet or the pos-
terior leaflet, we tend toward no resection and placement of artifi-
cial chordae, and it has been a more common practice in the recent
year, also.
When it comes to offering a patient an appropriate procedure,
we offer the patient an entire spectrum of the procedure and essen-
tially tailor the procedure to the patient. We always tell a patient
that our primary goal is to do a safe and effective operation and
our secondary goal is to do it through the smallest incision possi-
ble, and if we cannot do a safe and effective operation through
a small incision, we will use an incision that will allow us to do
a safe operation.t (kg),* body surface area (m2), body mass index (kg/m),x,{
thmia, heart failure
e, hypertension, peripheral arterial disease,k renal disease, diabetes, stroke,
esterol (mg/dL),y,x low-density lipoprotein (mg/dL), high-density
/dL), hematocrit (%),y,k bilirubin (mg/dL),x triglycerides (mg/dL)
al class (I–IV),*,x,{
index operation
rgitation,y,x left atrial diameter (cm), left atrial systolic area (cm2), LV
mild, 3 ¼ moderate, 4 ¼ severe), LV inner diastolic diameter (cm), LV
er systolic diameter (cm),x LVend-systolic volume (mL), LV fractional
,y posteriorwall thickness (cm),z intraventricular septalwall thickness (cm),
mass (g),y tricuspid valve regurgitation velocity (m/s), right ventricular
upturek
mitral valve; PST, partial sternotomy; ROB, robotic surgery. *Variables in CST versus
ST versus ROB parsimonious model. xVariables in PST versus ROB saturated model.
rated model.
ry c January 2011
FIGURE E1. Number of patients with pain score measurements available postoperatively and number of pain score measurements available for analysis
(black bars ¼ patients; grey bars ¼ pain score measurements). A, CST versus ROB. B, Partial sternotomy versus ROB. C, ANT versus ROB.
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FIGURE E2. Mirrored histograms of distribution of propensity scores ac-
cording to approach.Darker portionsof histograms representmatchedpatients.
A, CST versus ROB approach. B, PST versus ROB. C, ANT versus ROB.
FIGURE E3. Cardiopulmonary bypass time across date of operation for
the 2 surgeons performing robotic repair of posterior MV prolapse.
Grouped mean times (red and blue dots) represent approximately 20
patients grouped at the midpoint of calendar dates.
FIGURE E4. Myocardial ischemic time across date of operation for the 2
surgeons performing robotic repair of posterior MV prolapse. Grouped
mean times (red and blue dots) represent approximately 20 patients
grouped at the midpoint of calendar dates.
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FIGURE E5. Percentage of patients who are pain free postoperatively
according to surgical approach: propensity-matched patients.
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TABLE E1. Operative procedure according to surgical approach
Procedure
Complete sternotomy
(n ¼ 114)
Partial sternotomy
(n ¼ 270)
Mini-anterolateral thoracotomy
(n ¼ 114)
Robotic approach
(n ¼ 261) P
MV procedure
Anuloplasty 113 (99) 270 (100) 114 (100) 261 (100)
þLeaflet resection 105 (93) 257 (95) 112 (98) 243 (93) .2
Triangular 31 (27) 115 (43) 48 (42) 161 (62) <.0001
Quadrangular 74 (65) 142 (53) 64 (56) 82 (31) <.0001
þChordal procedure 5 (4.4) 5 (1.9) 0 (0) 8 (3.1) .1
þEdge-to-edge 4 (3.5) 15 (5.6) 3 (2.6) 26 (10) .02
MV replacement 1 (0.88) 0 (0) 0 (0) 0 (0) .1
Concomitant procedure
ASD or PFO closure 7 (6.1) 23 (8.5) 7 (6.1) 34 (13) .07
Left-sided ablative lesions for AF 31 (27) 5 (1.9) 7 (6.1) 22 (8.4) <.0001
AF, Atrial fibrillation; ASD, atrial septal defect; MV, mitral valve; PFO, patent foramen ovale.
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